We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
Cap. Flow
-$301M
Cap. Flow %
-0.68%
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
MSFT icon
Microsoft
MSFT
+$204M
3
JNJ icon
Johnson & Johnson
JNJ
+$157M
4
AMZN icon
Amazon
AMZN
+$144M
5
WMT icon
Walmart Inc
WMT
+$137M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Healthcare 16.49%
3 Financials 11.74%
4 Industrials 11.47%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLSK icon
2126
CleanSpark
CLSK
$2.97B
$56K ﹤0.01%
+14,303
New +$96.2K
ORIC icon
2127
Oric Pharmaceuticals
ORIC
$1.41B
$56K ﹤0.01%
+12,508
New +$49.9K
ROVR
2128
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$56K ﹤0.01%
14,784
VATE icon
2129
INNOVATE Corp
VATE
$97.3M
$55K ﹤0.01%
3,194
FRBK
2130
DELISTED
Republic First Bancorp Inc
FRBK
$55K ﹤0.01%
+14,451
New +$61.6K
ABUS icon
2131
Arbutus Biopharma
ABUS
$907M
$53K ﹤0.01%
+19,430
New +$49.7K
OTLK icon
2132
Outlook Therapeutics
OTLK
$215M
$53K ﹤0.01%
2,602
-266
-9% -$7.65K
OTRK
2133
DELISTED
Ontrak
OTRK
$53K ﹤0.01%
559
-2,811
-83% -$394K
KG
2134
Kestrel Group
KG
$67.3M
$52K ﹤0.01%
1,351
-1,542
-53% -$69K
UP icon
2135
Wheels Up
UP
$191M
$50K ﹤0.01%
127
+6
+5% +$3.21K
EXPR
2136
DELISTED
Express, Inc.
EXPR
$49K ﹤0.01%
+1,241
New +$74.5K
RCEL icon
2137
Avita Medical
RCEL
$235M
$48K ﹤0.01%
+10,086
New +$62.3K
BDTX icon
2138
Black Diamond Therapeutics
BDTX
$114M
$46K ﹤0.01%
18,663
+4,773
+34% +$11.1K
ATNX
2139
DELISTED
Athenex, Inc. Common Stock
ATNX
$45K ﹤0.01%
5,472
+2,939
+116% +$32.8K
PRAX icon
2140
Praxis Precision Medicines
PRAX
$10.2B
$43K ﹤0.01%
+1,160
New +$124K
RYTM icon
2141
Rhythm Pharmaceuticals
RYTM
$7.95B
$43K ﹤0.01%
10,295
+164
+2% +$898
ME
2142
DELISTED
23andMe Holding Co
ME
$41K ﹤0.01%
821
-361
-31% -$20.9K
BFX
2143
DELISTED
BowFlex Inc.
BFX
$40K ﹤0.01%
+22,587
New +$62.5K
GNLN icon
2144
Greenlane Holdings
GNLN
$1.23M
0
OMIC
2145
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$39K ﹤0.01%
+344
New +$40.3K
TSHA icon
2146
Taysha Gene Therapies
TSHA
$1.83B
$38K ﹤0.01%
+10,134
New +$40.2K
SLQT icon
2147
SelectQuote
SLQT
$123M
$34K ﹤0.01%
13,643
-84,071
-86% -$216K
SDC
2148
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$34K ﹤0.01%
33,156
+8,595
+35% +$13.9K
QSI icon
2149
Quantum-Si Incorporated
QSI
$172M
$33K ﹤0.01%
14,364
-2,070
-13% -$7.93K
MKFG
2150
DELISTED
Markforged Holding Corporation
MKFG
$30K ﹤0.01%
1,630

Similar funds

AQR Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
  • AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
  • AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
  • AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
  • AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
  • AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
  • AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.